Acknowledgement
본 연구는 보건복지부의 재원으로 한국보건산업진흥원의 보건의료기술연구개발사업 지원에 의하여 이루어진 것임(과제고유번호 : HF21C0092).
References
- Lane JM, Russell L, Khan SN. Osteoporosis. Clinical Orthopaedics and Related Research. 2000 ; (372) : 139-50. https://doi.org/10.1097/00003086-200003000-00016
- Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000 ; 289(5484) : 1508-14. https://doi.org/10.1126/science.289.5484.1508
- Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003 ; 423(6937) : 337-42. https://doi.org/10.1038/nature01658
- Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev. 2001 ; 11(5) : 527-32. https://doi.org/10.1016/s0959-437x(00)00228-8
- Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002 ; 2(4) : 389-406. https://doi.org/10.1016/s1534-5807(02)00157-0
- Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulaton of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999 ; 20(3) : 345-57. https://doi.org/10.1210/edrv.20.3.0367
- Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab. 2012 ; 23(11) : 582-90. https://doi.org/10.1016/j.tem.2012.05.005
- Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y, Kim HH. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun. 2006 ; 351(1) : 99-105. https://doi.org/10.1016/j.bbrc.2006.10.011
- Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. J Bone Metab. 2014 ; 21(4) : 233-41. https://doi.org/10.11005/jbm.2014.21.4.233
- Kim K, Lee SH, Kim JH, Choi Y, Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol. 2008 ; 22(1) : 176-85. https://doi.org/10.1210/me.2007-0237
- Reid IR. Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies. Skeletal Radiol. 2011 ; 40(9) : 1191-6. https://doi.org/10.1007/s00256-011-1164-9
- McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, et al. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med. 2013 ; 126(1) : 13-20. https://doi.org/10.1016/j.amjmed.2012.06.023
- Kim JY, Song YS. East-West medical examination of osteoporosis. J Korean Med Rehabil. 1996 ; 6(1) : 293-315.
- Medical College of Nanjing University of Traditional Chinese Medicine. Interpretation of the Yellow Emperor's Internal Classics. Shanghai. Shanghai Science and Technology Press. 1983 : 4-5.
- Herbology Editorial Committee of Korean Medicine : Herbology. Younglimsa 2009 ; 607-8.
- Oh MS, Kim DR, Kim SY, Chang MS, Park SK. Antioxidant Effects of Psoraleae Fructus in GC-1 Cells. J Physiol Pathol Korean Med. 2005 ; 19(1) : 81-6.
- Jeong JC, Jang YS, Min GW. Peroxynitrite Scavenging Mechanism of Psoralea corylifolia. J Int Korean Med. 2004 ; 25(2) : 268-76.
- Park YK, Kang BS. Effects of Psoraleae Semen on Antioxidation in Rat's liver. Kor J Herbol. 1996 ; 11(2) : 101-14.
- Seo BI, Kim SH. A Study on the Effects of Allii Tuberosi Semen in Ovariectomized Osteoporosis of Rats. Herbal Formula Science. 1997 ; 5(1) : 179-83.
- Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res. 2000 ; 15(1): 103-10. https://doi.org/10.1359/jbmr.2000.15.1.103
- Charles JF, Aliprantis AO. Osteoclasts: more than 'bone eaters'. Trends Mol Med. 2014 ; 20(8) : 449-59. https://doi.org/10.1016/j.molmed.2014.06.001
- Rumpler M, Wurger T, Roschger P, Zwettler E, Sturmlechner I, Altmann P, et al. Osteoclasts on Bone and Dentin In Vitro: Mechanism of Trail Formation and Comparison of Resorption Behavior. Calcif Tissue Int. 2013 ; 93(6) : 526-39. https://doi.org/10.1007/s00223-013-9786-7
- Zhao Q, Wang X, Liu Y, He A, Jia R. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol. 2010 ; 42(5) : 576-9. https://doi.org/10.1016/j.biocel.2009.12.018
- Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell. 2006 ; 10(6) : 771-82. https://doi.org/10.1016/j.devcel.2006.04.006
- Arai A, Mizoguchi T, Harada S, Kobayashi Y, Nakamichi Y, Yasuda H, et al. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. J Cell Sci. 2012 ; 125(Pt 12) : 2910-7. https://doi.org/10.1242/jcs.099986
- Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 ; 3(6) : 889-901. https://doi.org/10.1016/s1534-5807(02)00369-6
- Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999 ; 13(18) : 2412-24. https://doi.org/10.1101/gad.13.18.2412
- Pittayapruek P, Meephansan J, Prapapan O, Komine M, Ohtsuki M. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Int J Mol Sci. 2016 ; 17(6) : 868. https://doi.org/10.3390/ijms17060868
- Lehenkari P, Hentunen TA, Laitala-Leinonen T, Tuukkanen J, Vaananen HK. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. Exp Cell Res. 1998 ; 242(1) : 128-37. https://doi.org/10.1006/excr.1998.4071
- Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R, Hofbauer LC, et al. The role of osteoclast-associated receptor in osteoimmunology. J Immunol. 2011 ; 186(1) : 13-8. https://doi.org/10.4049/jimmunol.1002483
- Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest. 2011 ; 121(9) : 3505-16. https://doi.org/10.1172/JCI45913
- Kodama J, Kaito T. Osteoclast Multinucleation: Review of Current Literature. Int J Mol Sci. 2020 ; 21(16) : 5685. https://doi.org/10.3390/ijms21165685
- Wu H, Xu G, Li YP. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J Bone Miner Res. 2009 ; 24(5) : 871-85. https://doi.org/10.1359/jbmr.081239
- Chiu YH, Ritchlin CT. DC-STAMP: A Key Regulator in Osteoclast Differentiation. J Cell Physiol. 2016 ; 231(11) : 2402-7. https://doi.org/10.1002/jcp.25389
- Courtial N, Smink JJ, Kuvardina ON, Leutz A, Gothert JR, Lausen J. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J. 2012 ; 26(2) : 523-32. https://doi.org/10.1096/fj.11-190850